Published in Virology on May 01, 1987
Caveolae are involved in the trafficking of mouse polyomavirus virions and artificial VP1 pseudocapsids toward cell nuclei. J Virol (2001) 1.79
Requirements for different components of the host cell cytoskeleton distinguish ecotropic murine leukemia virus entry via endocytosis from entry via surface fusion. J Virol (1997) 1.75
Uptake pathway of polyomavirus via ganglioside GD1a. J Virol (2004) 1.63
Role of endosomes in simian virus 40 entry and infection. J Virol (2011) 1.46
Cell penetration and trafficking of polyomavirus. J Virol (2003) 1.36
Contrasting roles of endosomal pH and the cytoskeleton in infection of human glial cells by JC virus and simian virus 40. J Virol (2003) 1.36
Cytoplasmic trafficking of the canine parvovirus capsid and its role in infection and nuclear transport. J Virol (2000) 1.34
Entry of simian virus 40 is restricted to apical surfaces of polarized epithelial cells. Mol Cell Biol (1988) 1.33
Early events during BK virus entry and disassembly. J Virol (2008) 1.30
Involvement of cytoskeletal components in BK virus infectious entry. J Virol (2005) 1.27
Mouse polyomavirus enters early endosomes, requires their acidic pH for productive infection, and meets transferrin cargo in Rab11-positive endosomes. J Virol (2006) 1.16
Characterization of simian virus 40 receptor moieties on the surfaces of Vero C1008 cells. J Virol (1989) 1.12
Involvement of microtubular network and its motors in productive endocytic trafficking of mouse polyomavirus. PLoS One (2014) 0.79
A temperature-sensitive mutant of simian virus 40 affecting transforming ability. Virology (1973) 4.11
Rat cell line 3y1 and its virogenic polyoma- and sv40- transformed derivatives. Int J Cancer (1975) 3.53
Initiation and maintenance of cell transformation by simian virus 40: a viral genetic property. Proc Natl Acad Sci U S A (1975) 3.30
Isolation and characterization of temperature-sensitive mutants of simian virus 40. Virology (1972) 2.89
Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet (1997) 2.12
Genetic evidence for SV40 gene function in enhancement of replication of human adenovirus in simian cells. Nature (1974) 1.84
The role of intraalveolar fibrosis in the process of pulmonary structural remodeling in patients with diffuse alveolar damage. Am J Pathol (1987) 1.76
Depletion of the surface CD4 molecule by the envelope protein of human immunodeficiency virus expressed in a human CD4+ monocytoid cell line. J Virol (1989) 1.73
Cytopathic effect determined by the amount of CD4 molecules in human cell lines expressing envelope glycoprotein of HIV. J Immunol (1990) 1.69
Apoptosis induced in CD4+ cells expressing gp160 of human immunodeficiency virus type 1. J Virol (1994) 1.67
HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor. FEBS Lett (1997) 1.54
HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice. Cancer Res (2000) 1.47
Relationship of renal histological damage to glomerular hypertension in patients with immunoglobulin A nephropathy. J Hypertens (2000) 1.40
Similarity of nucleotide sequences around the origin of DNA replication in mouse polyoma virus and simian virus 40. Proc Natl Acad Sci U S A (1978) 1.33
Chloride reabsorption by renal proximal tubules of Necturus. J Membr Biol (1978) 1.25
Cardiovascular complications in patients with primary aldosteronism. Am J Kidney Dis (1999) 1.24
Possible clinical and histologic manifestations of adult-onset type II citrullinemia in early infancy. J Pediatr (2001) 1.20
Intracellular distribution of the envelope glycoprotein of human immunodeficiency virus and its role in the production of cytopathic effect in CD4+ and CD4- human cell lines. J Virol (1990) 1.20
Laparoscopically assisted distal gastrectomy for early gastric cancer: is it superior to open surgery? Surg Endosc (2000) 1.17
Ursodeoxycholate - in vitro cholesterol solubility and changes of composition of human gallbladder-bile after oral treatment. Life Sci (1977) 1.16
Diuretics shift circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation (1999) 1.13
Regional variations in the incidence of end-stage renal failure in Japan. JAMA (2000) 1.11
Depression of acquired resistance against herpes simplex virus infection in neonatally thymectomized mice. Arch Gesamte Virusforsch (1967) 1.10
Sodium restriction shifts circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation (1997) 1.10
Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor. Oncogene (1998) 1.09
Parkin is linked to the ubiquitin pathway. J Mol Med (Berl) (2001) 1.08
Priming of immature thymocytes to CD3-mediated apoptosis by infection with murine cytomegalovirus. J Virol (1994) 1.07
Expression of insulin-like growth factor (IGF)-II in human prostate, breast, bladder, and paraganglioma tumors. Cell Tissue Res (1998) 1.04
Laparoscopic treatment of duodenal carcinoid tumor. Wedge resection of the duodenal bulb under endoscopic control. Surg Endosc (1998) 1.03
PR3-ANCA-positive crescentic necrotizing glomerulonephritis accompanied by isolated pulmonic valve infective endocarditis, with reference to previous reports of renal pathology. Clin Nephrol (2006) 1.02
Pioglitazone shift circadian rhythm of blood pressure from non-dipper to dipper type in type 2 diabetes mellitus. Eur J Clin Invest (2007) 1.02
Vgamma1+ gammadelta T cells play protective roles at an early phase of murine cytomegalovirus infection through production of interferon-gamma. Immunology (2000) 1.02
Temperature-sensitive growth of cells transformed by ts-a mutant of polyoma virus. Nature (1975) 1.02
The thyrotropin receptor. Vitam Horm (1995) 1.01
Prevalence of renal artery stenosis in autopsy patients with stroke. Stroke (2000) 1.00
Role of systolic blood pressure in determining prognosis of hemodialyzed patients. Am J Kidney Dis (1995) 0.98
The difference in gp160 and gp120 of HIV type 1 in the induction of CD4 downregulation preceding single-cell killing. Virology (1994) 0.98
Tumor-reactive T-cells accumulate in lung cancer tissues but fail to respond due to tumor cell-derived factor. Cancer Res (1992) 0.97
The induction of smooth muscle alpha actin in a transformed rat cell line suppresses malignant properties in vitro and in vivo. Cancer Lett (1999) 0.97
Oral administration of PSK can improve the impaired anti-tumor CD4+ T-cell response in gut-associated lymphoid tissue (GALT) of specific-pathogen-free mice. Int J Cancer (1997) 0.96
Clinical evaluation of soluble cytokeratin 19 fragments (CYFRA 21-1) in serum and urine of patients with bladder cancer. Urology (1996) 0.94
Disturbance of nuclear transport of proteins in CD4+ cells expressing gp160 of human immunodeficiency virus. J Virol (1991) 0.94
Cytolytic potential of peripheral blood T-lymphocytes following adoptive immunotherapy with lymphokine-activated killer cells and low-dose interleukin 2. Cancer Res (1991) 0.94
High sodium sensitivity implicates nocturnal hypertension in essential hypertension. Hypertension (1996) 0.94
The involvement of transforming growth factor beta in the impaired antitumor T-cell response at the gut-associated lymphoid tissue (GALT). Cancer Res (1995) 0.94
Circadian rhythm of natriuresis is disturbed in nondipper type of essential hypertension. Am J Kidney Dis (1999) 0.94
Is a proliferation index of cancer cells a reliable prognostic factor after hepatectomy in patients with colorectal liver metastases? Am J Surg (2001) 0.93
Active production and membrane anchoring of carcinoembryonic antigen observed in normal colon mucosa. Cancer Lett (1988) 0.93
Differentiation of rat preadipocytes is accompanied by expression of thyrotropin receptors. Endocrinology (1996) 0.92
Induction of apoptosis by calmodulin-dependent intracellular Ca2+ elevation in CD4+ cells expressing gp 160 of HIV. Virology (1996) 0.92
Familial Parkinson's disease. Alpha-synuclein and parkin. Adv Neurol (2001) 0.92
Accumulation of p60lck in HTLV-I-transformed T cell lines detected by an anti-lck monoclonal antibody, MOL 171. Jpn J Cancer Res (1991) 0.91
Gingival salivary gland choristoma: an extremely rare phenomenon. Oral Surg Oral Med Oral Pathol (1983) 0.91
Murine cytomegalovirus-associated pneumonitis in the lungs free of the virus. J Clin Invest (1994) 0.91
Prevalence and predictors of renal artery stenosis in patients with myocardial infarction. Am J Kidney Dis (1997) 0.91
Luminal Na+ entry into Necturus proximal tubule cells. Am J Physiol (1979) 0.91
Regulation of the rat thyrotropin receptor gene by the methylation-sensitive transcription factor GA-binding protein. Mol Endocrinol (1998) 0.90
Nucleotide sequence around the replication origin of polyoma virus DNA. FEBS Lett (1977) 0.90
Xanthogranulomatous cholecystitis versus gallbladder cancer: clinical differentiating factors. Am Surg (1997) 0.90
Protective effects of hochu-ekki-to, a Chinese traditional herbal medicine against murine cytomegalovirus infection. Immunopharmacology (1999) 0.90
Role of the cyclic adenosine 3',5'-monophosphate response element in efficient expression of the rat thyrotropin receptor promoter. Mol Endocrinol (1992) 0.90
Parkin is associated with cellular vesicles. J Neurochem (2001) 0.89
Absence of transcription of lck (lymphocyte specific protein tyrosine kinase) message in IL-2-independent, HTLV-I-transformed T cell lines. J Immunol (1989) 0.89
A gender difference in the association between salt sensitivity and family history of hypertension. Am J Hypertens (1992) 0.89
Acute depressor effect of alcohol in patients with essential hypertension. Hypertension (1992) 0.89
Oligoclonal T lymphocytes infiltrating human lung cancer tissues. Int J Cancer (1991) 0.89
Role of macrophages in acute murine cytomegalovirus infection. Microbiol Immunol (1998) 0.89
Autosomal recessive juvenile parkinsonism: a key to understanding nigral degeneration in sporadic Parkinson's disease. Neuropathology (2000) 0.89
Acquisition of invasive phenotype in gallbladder cancer cells via mutual interaction of stromal fibroblasts and cancer cells as mediated by hepatocyte growth factor. Jpn J Cancer Res (1996) 0.88
Caspase-independent cell death and mitochondrial disruptions observed in the Apaf1-deficient cells. J Biochem (2001) 0.88
The antitumor activity induced by the in vivo administration of activated B cells bound to anti-CD3 monoclonal antibody. Cell Immunol (1995) 0.88
Functional expression of thyrotropin receptor in differentiated 3T3-L1 cells: a possible model cell line of extrathyroidal expression of thyrotropin receptor. Biochem Biophys Res Commun (1996) 0.87
A simulation study on transcellular fluid shifts induced by hemodialysis. Kidney Int (1983) 0.87
Molecular basis for the autoreactivity against thyroid stimulating hormone receptor. Int Rev Immunol (1992) 0.86
Characterization of CD4- CD8- CD3+ T-cell receptor-alphabeta+ T cells in murine cytomegalovirus infection. Immunology (2000) 0.86
The effect of p56lck, a lymphocyte specific protein tyrosine kinase, on the syncytium formation induced by human immunodeficiency virus envelope glycoprotein. Int Immunol (1992) 0.86
Abnormal gene expressions of stroma cells in patients with tuberous sclerosis. Ann N Y Acad Sci (1991) 0.86
Telomerase elevation in pancreatic ductal carcinoma compared to nonmalignant pathological states. Clin Cancer Res (1997) 0.86
Association of polymorphism in the NeuroD/BETA2 gene with type 1 diabetes in the Japanese. Diabetes (1999) 0.86
Characterization of an up-stream thyroid transcription factor-1-binding site in the thyrotropin receptor promoter. Endocrinology (1995) 0.86
Reduced ventricular response irregularity is associated with increased mortality in patients with chronic atrial fibrillation. Circulation (2000) 0.86
[Thoracoscopic repair of diaphragmatic eventration sustained at knife injury: a case report]. Kyobu Geka (1998) 0.85
Heat shock proteins and the antitumor T cell response. Biotherapy (1998) 0.85
Concomitant immunity against tumor development is enhanced by the oral administration of a kampo medicine, Hochu-ekki-to (TJ-41: Bu-Zhong-Yi-Qi-Tang). Immunopharmacol Immunotoxicol (1995) 0.85
Cyclooxygenase-2 expression and relationship to tumour progression in human renal cell carcinoma. Histopathology (2004) 0.85
Glomerular hypertension as one cause of albuminuria in type II diabetic patients. Diabetologia (1999) 0.85
Characteristics of alveolar macrophages in experimental septic lung. J Leukoc Biol (1992) 0.85
Idiopathic left innominate vein stenosis manifested following the creation of arteriovenous fistula in uremia. Am J Nephrol (1994) 0.85
Sodium and noradrenaline in cerebrospinal fluid and blood in salt-sensitive and non-salt-sensitive essential hypertension. Clin Exp Pharmacol Physiol (1992) 0.85
Induction of apoptosis of T cells by infecting mice with murine cytomegalovirus. J Virol (1995) 0.85
Characterization of the 5'-flanking region of the rat thyrotropin receptor gene. Mol Endocrinol (1992) 0.85
Striking effect of left ventricular systolic performance on propagation velocity of left ventricular early diastolic filling flow. J Am Soc Echocardiogr (2001) 0.84
Model prediction of plasma volume change induced by hemodialysis. J Lab Clin Med (1984) 0.84
Changes in the configuration of the rabbit atrial action potential after various periods of rest. Jpn J Physiol (1967) 0.84
A model of port-site metastases of gallbladder cancer: the influence of peritoneal injury and its repair on abdominal wall metastases. Surgery (1999) 0.83
Extensive apoptosis occurring in the thymus during accelerated rejection of cardiac allografts in presensitized rats. J Immunol (1993) 0.83
Genetic analysis of control of proliferation in fibroblastic cells in culture. I. Isolation and characterization of mutants temperature-sensitive for proliferation or survival of untransformed diploid rat cell line 3Y1. Somat Cell Mol Genet (1984) 0.83
Cloning of the single strand DNA-binding protein important for maximal expression and thyrotropin (TSH)-induced negative regulation of the TSH receptor. Mol Endocrinol (1996) 0.83
Characterization of B16 melanoma-specific cytotoxic T lymphocytes. Cancer Immunol Immunother (1998) 0.83